adisinsight.springer.com
- Domain
- adisinsight.springer.com
- Category
- Uncategorized
- Publisher
- springer.com
Top References from adisinsight.springer.com
| Score | Article | Date | Citations |
|---|---|---|---|
| 7.0 |
EXV 801https://adisinsight.springer.com/drugs/800085769 |
N/A | 2 |
| 7.0 |
Oxymetazolinehttps://adisinsight.springer.com/drugs/800086617 |
N/A | 2 |
| 7.0 |
Deuterated testosteronehttps://adisinsight.springer.com/drugs/800065467 |
N/A | 2 |
| 7.0 |
RE 104https://adisinsight.springer.com/drugs/800074379 |
N/A | 2 |
| 7.0 |
IRL 757https://adisinsight.springer.com/drugs/800069085 |
N/A | 2 |
| 7.0 |
SB 247853https://adisinsight.springer.com/drugs/800016366 |
N/A | 2 |
| 7.0 |
Ondansetron/Pramipexolehttps://adisinsight.springer.com/drugs/800082563 |
N/A | 2 |
| 7.0 |
BMB 105https://adisinsight.springer.com/drugs/800085290 |
N/A | 2 |
| 3.5 |
Research programme: depressive disorder diagnostics and therapeutics - Toronto Innovation Acceleration Partners/Johnson & Johnson/CAMH - AdisInsighthttps://adisinsight.springer.com/drugs/800041947 |
N/A | 1 |
| 3.5 |
Opus Geneticshttps://adisinsight.springer.com/drugs/800043975 |
N/A | 1 |
| 3.5 |
Lithium cocrystal - Alzamend Neuro - AdisInsighthttps://adisinsight.springer.com/drugs/800058554 |
N/A | 1 |
| 3.5 |
Research programme: psychiatric disorder therapeutics - NeuroProfile - AdisInsighthttps://adisinsight.springer.com/drugs/800047343 |
N/A | 1 |
| 3.5 |
Research programme: reuptake inhibitors - Neurovance - AdisInsighthttps://adisinsight.springer.com/drugs/800027403 |
N/A | 1 |
| 3.5 |
Research programme: antidepressants - Clera - AdisInsighthttps://adisinsight.springer.com/drugs/800020943 |
N/A | 1 |
| 3.5 |
Research programme: GPCR modulators - Nxera Pharma - AdisInsighthttps://adisinsight.springer.com/drugs/800029765 |
N/A | 1 |
| 3.5 |
Vanda Pharmaceuticalshttps://adisinsight.springer.com/drugs/800064652 |
N/A | 1 |
| 3.5 |
ORG 37684https://adisinsight.springer.com/drugs/800009204 |
N/A | 1 |
| 3.5 |
ABS 201 - Absci - AdisInsighthttps://adisinsight.springer.com/drugs/800081953?error=cookies_not_supported&code=dfbe1d5c-2318-44e2-ba70-e068fe0a2360 |
N/A | 1 |
| 3.5 |
Valiloxybatehttps://adisinsight.springer.com/drugs/800051495 |
N/A | 1 |
| 3.5 |
LY 03017https://adisinsight.springer.com/drugs/800078298 |
N/A | 1 |
| 3.5 |
ABS 201 - Absci - AdisInsighthttps://adisinsight.springer.com/drugs/800081953?error=cookies_not_supported&code=a5bb5e27-e746-4f78-a5cf-858aa6148e21 |
N/A | 1 |
| 3.5 |
Research programme: hydroxynorketamine derivatives - Spirify Pharma - AdisInsighthttps://adisinsight.springer.com/drugs/800071092 |
N/A | 1 |
| 3.5 |
Nelivaptan companion diagnostic - HMNC Brain Health - AdisInsighthttps://adisinsight.springer.com/drugs/800067125 |
N/A | 1 |
| 3.5 |
Research programme: serotonin reuptake inhibitors/serotonin 1A receptor antagonists - Pfizer - AdisInsighthttps://adisinsight.springer.com/drugs/800013819 |
N/A | 1 |
| 3.5 |
Research programme: allosteric modulators - Addex Therapeutics - AdisInsighthttps://adisinsight.springer.com/drugs/800024111 |
N/A | 1 |
| 3.5 |
Research programme: depressive disorder and dysuria therapeutics - Alvogen Korea - AdisInsighthttps://adisinsight.springer.com/drugs/800045467 |
N/A | 1 |
| 3.5 |
CNS 5161https://adisinsight.springer.com/drugs/800009030 |
N/A | 1 |
| 3.5 |
Research programme: NMDA receptor modulators - AbbVie - AdisInsighthttps://adisinsight.springer.com/drugs/800031388 |
N/A | 1 |
| 3.5 |
Etrabaminehttps://adisinsight.springer.com/drugs/800003368 |
N/A | 1 |
| 3.5 |
ATHX 105https://adisinsight.springer.com/drugs/800024939 |
N/A | 1 |
| 3.5 |
UK 447841https://adisinsight.springer.com/drugs/800039893 |
N/A | 1 |
| 3.5 |
HDM 1002https://adisinsight.springer.com/drugs/800078896 |
N/A | 1 |
| 3.5 |
Adrogolidehttps://adisinsight.springer.com/drugs/800006590 |
N/A | 1 |
| 3.5 |
TGFK 09SDhttps://adisinsight.springer.com/drugs/800032503 |
N/A | 1 |
| 3.5 |
SKF 81297https://adisinsight.springer.com/drugs/800004119 |
N/A | 1 |
| 3.5 |
Carvotrolinehttps://adisinsight.springer.com/drugs/800001398 |
N/A | 1 |
| 3.5 |
Research programme: glycogen synthase kinase-3 inhibitors - Kemia - AdisInsighthttps://adisinsight.springer.com/drugs/800023142 |
N/A | 1 |
| 3.5 |
S 32504https://adisinsight.springer.com/drugs/800012906 |
N/A | 1 |
| 3.5 |
Research programme: CNS disorders therapeutics - Sage Therapeutics - AdisInsighthttps://adisinsight.springer.com/drugs/800035109 |
N/A | 1 |
| 3.5 |
KH 001 - AdisInsighthttps://adisinsight.springer.com/drugs/800069314 |
N/A | 1 |
| 3.5 |
ART 2713https://adisinsight.springer.com/drugs/800039083 |
N/A | 1 |
| 3.5 |
Miltironehttps://adisinsight.springer.com/drugs/800003466 |
N/A | 1 |
| 3.5 |
ENX 205https://adisinsight.springer.com/drugs/800081470 |
N/A | 1 |
| 3.5 |
AKO 004 - AdisInsighthttps://adisinsight.springer.com/drugs/800064701 |
N/A | 1 |
| 3.5 |
Botulinum toxin - CKD Bio Corporation - AdisInsighthttps://adisinsight.springer.com/drugs/800067923 |
N/A | 1 |
| 3.5 |
Research programme: mood disorder and neurological disorder therapeutics - Phenoquest - AdisInsighthttps://adisinsight.springer.com/drugs/800033448 |
N/A | 1 |
| 3.5 |
SCH 50971https://adisinsight.springer.com/drugs/800004504 |
N/A | 1 |
| 3.5 |
Omecamtiv mecarbilhttps://adisinsight.springer.com/drugs/800024924 |
N/A | 1 |
| 3.5 |
DAR 100https://adisinsight.springer.com/drugs/800017069 |
N/A | 1 |
| 3.5 |
Research programme: small tryptamine derivatives - Marvel Biosciences - AdisInsighthttps://adisinsight.springer.com/drugs/800075395 |
N/A | 1 |